DNAnexus has appointed Arthur Cole as general manager of Europe. He will be based in the UK and will be responsible for the company's marketing, sales, and business development activities across the European market. He joins DNAnexus from Debon Strategic Partners, and was also previously executive vice president of Visible Genetics.
DiaDexus has appointed Ralf Schoenbrunner as senior vice president of research and early development. Previously, he was vice president of research and development andmolecular diagnostics at Life Technologies. He holds a PhD in physical biochemistry from the University of Bayreuth in Germany.
Epic Sciences has appointed Murali Prahalad as President and CEO. Prahalad joins Epic from Life Technologies where he was vice president of corporate strategy and helped shape investment priorities in research tools, clinical diagnostics, and applied markets.